For example: Apple Inc, UTIL, Aluminum
West Pharmaceutical Services Inc
NYSE:WST
Market Close 11/27
277.96 USD +8.76 (+3.25%)
OPEN:
271.65
DAY RANGE:
271.65 - 278.00
PE:
40.37
PB:
5.20
PS:
5.22
WTD % -2.38
MTD % 2.16
QTD % 1.11
YTD % 84.90
* Updated at market close
West Pharmaceutical Services Inc (NYSE:WST) opened on Nov 27, 2020 at 271.65 USD and scaled up by 3.25%. The intraday price range was 271.65 - 278.00 USD and eventually ended the session at 277.96 USD. The stock trade volume was 190,500.00 shares. The company's 52-week range is 124.53 - 305.00 USD.
Trading Statistics (Market Close Nov 27, 2020)
Market Cap 20.52 B
Outstanding Stock 74.08 M
Dividend 0.15
Dividend Yield 0.50%
EPS 3.10
YTD Change 84.90%
52 Week's Range 124.53 - 305.00
Key Ratio & Margins (Market Close Nov 27, 2020)
Price/Earning 40.37
Price/Book Value 5.20
Price/Sales 5.22
ROA -
ROE -
Debt/Equity 0.47
Company Self Description
West Pharmaceutical Services, Inc. manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, and internationally. The company operates through two segments, Proprietary Products, and Contract-Manufactured Products. It was founded in 1923 and is headquartered in Exton, Pennsylvania, United States.
Business Information
West Pharmaceutical Services Inc
Sector Health Care
Industry Health Care Equipment & Supplies
Exchange NYSE
Top Competitors (Market Close Nov 27, 2020)
  WST HOLX COO TFX
Daily Change (%) 3.25 1.88 3.56 -0.70
WTD (%) -2.38 0.75 2.82 0.12
MTD (%) 2.16 1.00 6.79 16.60
QTD (%) 1.11 4.57 1.06 9.00
YTD (%) 84.90 33.14 6.04 -1.43
52-Week Change (%) 85.01 35.23 7.49 4.94
Stock Performance (Market Close Nov 27, 2020)
  WST HOLX COO TFX
Daily Change (%) 3.25 1.88 3.56 -0.70
WTD (%) -2.38 0.75 2.82 0.12
MTD (%) 2.16 1.00 6.79 16.60
QTD (%) 1.11 4.57 1.06 9.00
YTD (%) 84.90 33.14 6.04 -1.43
52-Week Change (%) 85.01 35.23 7.49 4.94
Key Fundamentals (Market Close Nov 27, 2020)
  WST HOLX COO TFX
Market Cap 20.52 B 18.00 B 18.17 B 17.26 B
Revenue Growth - - - -
Net Income Growth - - - -
Profit Margin 12.90% -0.90% 16.50% 10.80%
P/E Ratio 40.37 -436.55 33.44 56.13
Price to Sales Ratio 5.22 3.90 5.52 6.07
Price to Book Ratio 5.20 4.59 3.84 4.68
Enterprise Value to EBITDA 19.83 65.81 21.51 35.31
ROA - -0.40% 6.90% 4.30%
ROE - -1.30% 12.70% 10.60%
Debt/Equity 0.47 1.98 0.85 1.47
Asset Turnover Ratio 0.87 0.49 0.42 0.40
Current Ratio 3.15 1.23 2.03 2.12
Dividend Yield 0.50% 0 0 0.40%
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Revenue 1.72 B 1.60 B 1.51 B 1.40 B
Cost Of Revenue 1.17 B 1.09 B 1.01 B 944.00 M
Gross Profit 545.40 M 512.90 M 501.40 M 455.80 M
Selling General & Administrative Expenses 262.90 M 246.00 M 239.60 M 233.00 M
Research & Development 40.30 M 39.10 M 36.80 M 34.10 M
Operating Income 240.30 M 225.80 M 195.20 M 128.60 M
Net Income 206.90 M 150.70 M 143.60 M 95.60 M
EPS 2.80 2.04 1.96 1.33
Diluted EPS 2.74 1.99 1.91 1.30
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Revenue 469.70 M 443.50 M 422.50 M 431.70 M
Cost Of Revenue 311.80 M 296.70 M 289.30 M 296.10 M
Gross Profit 157.90 M 146.80 M 133.20 M 135.60 M
Selling General & Administrative Expenses 70.30 M 68.60 M 59.70 M 64.90 M
Research & Development 9.60 M 9.80 M 9.80 M 10.10 M
Operating Income 78.00 M 68.40 M 61.80 M 60.60 M
Net Income 66.10 M 55.40 M 52.00 M 55.20 M
EPS 0.90 0.75 0.70 0.75
Diluted EPS 0.88 0.73 0.69 0.73
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Total Current Assets 894.40 M 743.50 M 641.90 M 673.70 M
Cash & Cash Equivalents 337.40 M 235.90 M 203.00 M 274.60 M
Total Assets 1.98 B 1.86 B 1.72 B 1.70 B
Total Current Liabilities 283.70 M 279.50 M 241.00 M 314.30 M
Total Liabilities 582.60 M 582.90 M 599.20 M 671.20 M
Shareholder's Equity 1.40 B 1.28 B 1.12 B 1.02 B
Outstanding Stock 74.08 M 74.25 M 73.18 M 72.09 M
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Total Current Assets 944.30 M 867.60 M 894.40 M 850.10 M
Cash & Cash Equivalents 326.70 M 265.50 M 337.40 M 297.30 M
Total Assets 2.12 B 2.04 B 1.98 B 1.95 B
Total Current Liabilities 313.20 M 301.10 M 283.70 M 288.80 M
Total Liabilities 678.10 M 666.70 M 582.60 M 594.30 M
Shareholder's Equity 1.45 B 1.37 B 1.40 B 1.35 B
Outstanding Stock 73.48 M 74.19 M 74.08 M 73.54 M
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Net Cash Flow from Operations 288.60 M 263.30 M 219.40 M 212.40 M
Capital Expenditures -104.70 M -130.80 M -170.20 M -131.60 M
Net Cash Flow from Investing Activities -100.80 M -133.60 M -175.80 M -129.50 M
Net Cash Flow from Financial Activities -80.70 M -109.00 M -113.90 M -41.50 M
Free Cash Flow 183.90 M 132.50 M 49.20 M 80.80 M
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Net Cash Flow from Operations 105.10 M 263.30 M 219.40 M 212.40 M
Capital Expenditures -28.30 M -28.80 M -30.00 M -26.50 M
Net Cash Flow from Investing Activities -47.10 M -28.70 M -28.60 M -26.50 M
Net Cash Flow from Financial Activities 3.10 M -90.50 M -8.20 M 10.10 M
Free Cash Flow 76.80 M 18.80 M 43.20 M 61.90 M
Key Ratios (Market Close Nov 27, 2020)
Valuation Ratios 2020 2019 2018 2017
P/E Ratio 40.37 37.23 35.01 58.80
Price to Sales Ratio 5.22 4.68 4.22 5.33
Price to Book Ratio 5.20 5.72 5.56 4.24
Enterprise Value to EBIT 28.00 30.00 30.00 32.00
Enterprise Value to EBITDA 19.83 21.68 21.00 19.42
Profitability Ratios 2020 2019 2018 2017
Revenue Growth - - - -
Net Income Growth - - - -
ROA - - 10.80% 8.20%
ROE - - 15.50% 12.00%
Liquidity Ratios 2020 2019 2018 2017
Working Capital 610.70 M 464.00 M 400.90 M 359.40 M
Current Ratio 3.15 2.66 2.66 2.14
Efficiency & Capital Structure Ratios 2020 2019 2018 2017
Debt Equity Ratio 0.47 0.46 0.54 0.66
Asset Turnover Ratio - - 0.90 0.87
Scratchpad (max of 30 tickers)
Symbol Last Price Change
Empty Scratchpad
Portfolio (max of 30 tickers)
Login is required to view your portfolio.